BIO Congratulates Dr. Scott Gottlieb on Confirmation as FDA Commissioner

Washington, DC (May 9, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration (FDA):

BIO Thanks Sen. Wyden for Clean Fuel Production Tax Credit Proposal

BIO today thanked Sen. Ron Wyden (D-OR) and 21 Senate co-sponsors for proposing a technology neutral tax credit for domestic production of clean transportation fuel. Sen. Wyden’s Clean Energy for America Act proposes a set of long-term energy tax incentives that are available to all technologies and promote performance based clean energy in the United States. BIO supports Sen. Wyden’s efforts to ensure that any tax reform package Congress considers includes incentives that promote the development and production of advanced and cellulosic biofuels.

BIO Applauds Bipartisan Introduction of the PARTNER Act

Washington, DC (May 4, 2017) – Today, the Biotechnology Innovation Organization (BIO) thanks Reps. Pat Meehan (R-PA), Richard Neal (D-MA), Mike Kelly (R-PA), Ron Kind (D-WI), and John Larson (D-CT) for introducing the Partnerships to Advance Revolutionary Technology and Novel Entrepreneurial Research (PARTNER) Act.  This important legislation would support early-stage capital formation by incentivizing investment in R&D-focused small businesses.

BIO Partners with NIH and NSF for Fourth “Innovation Zone” Exhibit

SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2017 International Convention 

Report Shows GM Crops Favored by World’s Farmers

Global Adoption of Biotech Crops Reaches New Peak of 457 Million Acres Washington, D.C. (May 4, 2017) – Millions of farmers around the world continue to choose genetically modified (GM) crop varieties because of their environmental and socio-economic benefits and the important role they play in addressing food security, according to a study released today.

BIO Statement on Blue Cross Blue Shield Prescription Drug Spending Report

Washington, DC (May 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding today’s prescription...

BIO World Congress Announces New Education Track and Plenary Session on Food Ingredients and Personal Care

The 2017 BIO World Congress on Industrial Biotechnology education program features seven diverse education tracks with speakers from around the world over three days of the conference.

BIO Statement on Release of USTR’s 2017 “Special 301 Report”

USTR’s 2017 report addresses many of the key IP-related challenges that BIO members face globally.

BIO Comment on EPA’s Renewables Enhancement and Growth Support (REGS) Proposed Rule

BIO supports EPA’s ongoing efforts to improve the efficiency and effectiveness of the federal Renewable Fuel Standard (“RFS”) program, which was created by Congress, with bipartisan support, in statutory provisions that President George W. Bush signed into law as part of the Energy Policy Act of 2005 and Energy Independence and Security Act of 2007.

BIO Comment on EPA's Proposed Denial of Petitions for Rulemaking to Change the RFS Point of Obligation

BIO is supportive of EPA’s proposal. In BIO’s view, granting the petitions in question would add unnecessary regulatory complexity and uncertainty to the Renewable Fuel Standard ("RFS") program, jeopardize U.S. economic and job growth, and would fail to further the statutory requirements and goals that Congress directed EPA to enforce and pursue when Congress created the program.